Nicola Fusco, M.D.
Nicola Fusco, M.D.
European Institute of Oncology (IEO), University of Milan, Italy
Email verificata su
Citata da
Citata da
Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands
I Weinreb, S Piscuoglio, LG Martelotto, D Waggott, CKY Ng, ...
Nature genetics 46 (11), 1166-1169, 2014
The genomic landscape of male breast cancers
S Piscuoglio, CKY Ng, MP Murray, E Guerini-Rocco, LG Martelotto, ...
Clinical Cancer Research 22 (16), 4045-4056, 2016
MED12 somatic mutations in fibroadenomas and phyllodes tumours of the breast
S Piscuoglio, M Murray, N Fusco, C Marchiò, FL Loo, LG Martelotto, ...
Histopathology 67 (5), 719-729, 2015
Expression and clinical significance of the autophagy proteins BECLIN 1 and LC3 in ovarian cancer
G Valente, F Morani, G Nicotra, N Fusco, C Peracchio, R Titone, O Alabiso, ...
BioMed research international 2014, 2014
PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine?
N Fusco, E Sajjadi, K Venetis, G Gaudioso, G Lopez, C Corti, EG Rocco, ...
Genes 11 (7), 719, 2020
Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer
N Fusco, FC Geyer, MR De Filippo, LG Martelotto, CKY Ng, S Piscuoglio, ...
Modern Pathology 29 (11), 1292-1305, 2016
PIK3CA Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
N Fusco, U Malapelle, M Fassan, C Marchiò, S Buglioni, S Zupo, ...
Frontiers in Oncology 11, 644737, 2021
MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYBNFIB fusion gene
J Kim, FC Geyer, LG Martelotto, CKY Ng, RS Lim, P Selenica, A Li, ...
The Journal of pathology 244 (2), 143-150, 2018
Mismatch repair protein loss as a prognostic and predictive biomarker in breast cancers regardless of microsatellite instability
N Fusco, G Lopez, C Corti, C Pesenti, P Colapietro, G Ercoli, G Gaudioso, ...
JNCI Cancer Spectrum 2 (4), pky056, 2018
Tackling the diversity of breast cancer related lymphedema: perspectives on diagnosis, risk assessment, and clinical management
A Michelotti, M Invernizzi, G Lopez, D Lorenzini, F Nesa, A De Sire, ...
The Breast 44, 15-23, 2019
HER2 in gastric cancer: a digital image analysis in pre-neoplastic, primary and metastatic lesions
N Fusco, EG Rocco, C Del Conte, C Pellegrini, G Bulfamante, F Di Nuovo, ...
Modern Pathology 26 (6), 816-824, 2013
HER2 low, ultra-low, and novel complementary biomarkers: expanding the spectrum of HER2 positivity in breast cancer
K Venetis, E Crimini, E Sajjadi, C Corti, E Guerini-Rocco, G Viale, ...
Frontiers in molecular biosciences 9, 834651, 2022
The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis‐generating study
E Guerini‐Rocco, Z Hodi, S Piscuoglio, CKY Ng, EA Rakha, ...
The Journal of pathology 237 (2), 166-178, 2015
Microglandular adenosis associated with triple‐negative breast cancer is a neoplastic lesion of triple‐negative phenotype harbouring TP53 somatic mutations
E Guerini‐Rocco, S Piscuoglio, CKY Ng, FC Geyer, MR De Filippo, ...
The Journal of pathology 238 (5), 677-688, 2016
Targeting immune-related biological processes in solid tumors: we do need biomarkers
F Pagni, E Guerini-Rocco, AM Schultheis, G Grazia, E Rijavec, M Ghidini, ...
International journal of molecular sciences 20 (21), 5452, 2019
Impact of rehabilitation on breast cancer related fatigue: a pilot study
M Invernizzi, A De Sire, L Lippi, K Venetis, E Sajjadi, F Gimigliano, ...
Frontiers in Oncology 10, 556718, 2020
Myostatin as a potential biomarker to monitor sarcopenia in hip fracture patients undergoing a multidisciplinary rehabilitation and nutritional treatment: a preliminary study
A de Sire, A Baricich, F Renò, C Cisari, N Fusco, M Invernizzi
Aging clinical and experimental research 32, 959-962, 2020
The role of the pathologist in the next-generation era of tumor molecular characterization
V Angerilli, F Galuppini, F Pagni, N Fusco, U Malapelle, M Fassan
Diagnostics 11 (2), 339, 2021
HER2 aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists
N Fusco, S Bosari
World Journal of Gastroenterology 22 (35), 7926, 2016
Axillary web syndrome in women after breast cancer surgery referred to an Oncological Rehabilitation Unit: Which are the main risk factors? A retrospective case-control study
A De Sire, L Losco, C Cisari, A Gennari, R Boldorini, N Fusco, E Cigna, ...
European review for medical and pharmacological sciences 24 (15), 8028-8035, 2020
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20